Wine drinking and epithelial ovarian cancer risk: A meta-analysis

Journal of Gynecologic Oncology

Volumn 21, Issue 2, 2010, Pages 112-118

  Kim, Hee Seung ^a   Kim, Jae Weon ^a   Shouten, Leo J ^b   Larsson, Susanna C ^c   Chung, Hyun Hoon ^a   Kim, Yong Beom ^d   Ju, Woong ^e   Park, Noh Hyun ^a   Song, Yong Sang ^a,f   Kim, Seung Cheol ^e   Kang, Soon Beom ^a  

^a Seoul National University College of Medicine   (South Korea)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c KAROLINSKA INSTITUTE   (Sweden)

^d Seoul National University Bundang Hospital   (South Korea)

^e Ewha Womans University School of Medicine   (South Korea)

^f Seoul National University   (South Korea)

Author keywords

Epithelial ovarian cancer; Resveratrol; Wine

Indexed keywords

RESVERATROL;

ARTICLE; CANCER RISK; CLINICAL TRIAL; DRINKING BEHAVIOR; EPITHELIAL OVARIAN CANCER; HUMAN; META ANALYSIS; OVARY CANCER; SYSTEMATIC REVIEW; WINE;

EID: 77954504855     PISSN: 20050380     EISSN: 20050399     Source Type: Journal    
DOI: 10.3802/jgo.2010.21.2.112     Document Type: Article

References (40)

1. Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol 2006; 20: 207-25.
2. Kim K, Ryu SY. Major clinical research advances in gynecologic cancer 2009. J Gynecol Oncol 2009; 20: 203-9.
3. Heintz AP, Odicino F, Maisonneuve P, Quinn MA, Benedet JL, Creasman WT, et al. Carcinoma of the ovary: FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 2006; 95 Suppl 1: S161-92.
4. Ozols RF, Bundy BN, Greer BE, Fowler JM, Clarke-Pearson D, Burger RA, et al. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol 2003; 21: 3194-200.
5. Blagden S, Gabra H. Promising molecular targets in ovarian cancer. Curr Opin Oncol 2009; 21: 412-9.
6. Goswami SK, Das DK. Resveratrol and chemoprevention. Cancer Lett 2009; 284: 1-6.
7. Raj MH, Abd Elmageed ZY, Zhou J, Gaur RL, Nguyen L ,Azam GA, et al. Synergistic action of dietary phyto-antioxidants on survival and proliferation of ovarian cancer cells. Gynecol Oncol 2008; 110: 432-8.
8. Park SY, Jeong KJ, Lee J, Yoon DS, Choi WS, Kim YK, et al. Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: their inhibition by resveratrol. Cancer Lett 2007; 258: 63-9. (Pubitemid 47600493)
9. Kueck A, Opipari AW Jr, Griffith KA, Tan L, Choi M, Huang J, et al. Resveratrol inhibits glucose metabolism in human ovarian cancer cells. Gynecol Oncol 2007; 107: 450-7. (Pubitemid 350160855)
10. Tyagi A, Singh RP, Agarwal C, Siriwardana S, Sclafani RA, Agarwal R. Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells. Carcinogenesis 2005; 26: 1978-87. (Pubitemid 41631273)
11. Opipari AW Jr, Tan L, Boitano AE, Sorenson DR, Aurora A, Liu JR. Resveratrol-induced autophagocytosis in ovarian cancer cells. Cancer Res 2004; 64: 696-703. (Pubitemid 38120912)
12. Larsson SC, Giovannucci E, Wolk A. Dietary folate intake and incidence of ovarian cancer: the Swedish Mammography Cohort. J Natl Cancer Inst 2004; 96: 396-402. (Pubitemid 38351301)
13. Schouten LJ, Zeegers MP, Goldbohm RA, van den Brandt PA. Alcohol and ovarian cancer risk: results from the Netherlands Cohort Study. Cancer Causes Control 2004; 15: 201-9.
14. Chang ET, Canchola AJ, Lee VS, Clarke CA, Purdie DM, Reynolds P, et al. Wine and other alcohol consumption and risk of ovarian cancer in the California Teachers Study cohort. Cancer Causes Control 2007; 18: 91-103.
15. Gwinn ML, Webster LA, Lee NC, Layde PM, Rubin GL. Alcohol consumption and ovarian cancer risk. Am J Epidemiol 1986; 123: 759-66.
16. La Vecchia C, Negri E, Franceschi S, Parazzini F, Gentile A, Fasoli M. Alcohol and epithelial ovarian cancer. J Clin Epidemiol 1992; 45: 1025-30.
17. Tavani A, Gallus S, Dal Maso L, Franceschi S, Montella M, Conti E, et al. Coffee and alcohol intake and risk of ovarian cancer: an Italian case-control study. Nutr Cancer 2001; 39: 29-34. (Pubitemid 32880945)
18. Goodman MT, Tung KH. Alcohol consumption and the risk of borderline and invasive ovarian cancer. Obstet Gynecol 2003; 101: 1221-8.
19. Modugno F, Ness RB, Allen GO. Alcohol consumption and the risk of mucinous and nonmucinous epithelial ovarian cancer. Obstet Gynecol 2003; 102: 1336-43. (Pubitemid 37518416)
20. Webb PM, Purdie DM, Bain CJ, Green AC. Alcohol, wine, and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2004; 13: 592-9.
21. Peterson NB, Trentham-Dietz A, Newcomb PA, Chen Z, Hampton JM, Willett WC, et al. Alcohol consumption and ovarian cancer risk in a population-based case-control study. Int J Cancer 2006; 119: 2423-7. (Pubitemid 44215540)
22. Rosenberg L, Slone D, Shapiro S, Kaufman DW, Helmlich SP, Miettinen OS, et al. Breast cancer and alcoholic-beverage consumption. Lancet 1982; 1: 267-70.
23. Celik Y, Temizoz O, Genchellac H, Cakir B, Asil T. A non-alcoholic patient with acute Marchiafava-Bignami disease associated with gynecologic malignancy: paraneoplastic Marchiafava-Bignami disease? Clin Neurol Neurosurg 2007; 109: 505-8.
24. Yang SH, Kim JS, Oh TJ, Kim MS, Lee SW, Woo SK, et al. Genome-scale analysis of resveratrol-induced gene expresssion profile in human ovarian cancer cells using a cDNA microarray. Int J Oncol 2003; 22: 741-50.
25. Larsson SC, Wolk A. Wine consumption and epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2004; 13: 1823.
26. Gallus S, Scotti L, Talamini R, Franceschi S, Dal Maso L, Negri E, et al. Reply to: alcohol consumption and ovarian cancer risk in a population-based case-control study by Peterson et al. Int J Cancer 2007; 121: 2578-9. (Pubitemid 350022432)
27. Genkinger JM, Hunter DJ, Spiegelman D, Anderson KE, Buring JE, Freudenheim JL, et al. Alcohol intake and ovarian cancer risk: a pooled analysis of 10 cohort studies. Br J Cancer 2006; 94: 757-62.
28. Tworoger SS, Gertig DM, Gates MA, Hecht JL, Hankinson SE. Caffeine, alcohol, smoking, and the risk of incident epithelial ovarian cancer. Cancer 2008; 112: 1169-77.
29. Chang ET, Lee VS, Canchola AJ, Dalvi TB, Clarke CA, Reynolds P, et al. Dietary patterns and risk of ovarian cancer in the California Teachers Study cohort. Nutr Cancer 2008; 60: 285-91.
30. Higgins JP, Thompson SG, Deeks JJ, Airman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
31. Sterne JA, Egger M. Funnel plots for detecting bias in meta analysis: guidelines on choice of axis. J Clin Epidemiol 2001; 54: 1046-55.
32. Ho SM. Estrogen, progesterone and epithelial ovarian cancer. Reprod Biol Endocrinol 2003; 1: 73.
33. Singletary KW, Gapstur SM. Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms. JAMA 2001; 286: 2143-51.
34. Cooper GS, Sandler DP, Whelan EA, Smith KR. Association of physical and behavioral characteristics with menstrual cycle patterns in women age 29-31 years. Epidemiology 1996; 7: 624-8.
35. Rimando AM, Cuendet M, Desmarchelier C, Mehta RG, Pezzuto JM, Duke SO. Cancer chemopreventive and antioxidant activities of pterostilbene, a naturally occurring analogue of resveratrol. J Agric Food Chem 2002; 50: 3453-7. (Pubitemid 34580577)
36. Wolter F, Clausnitzer A, Akoglu B, Stein J. Piceatannol, a natural analog of resveratrol, inhibits progression through the S phase of the cell cycle in colorectal cancer cell lines. J Nutr 2002; 132: 298-302. (Pubitemid 34135611)
37. Potter GA, Patterson LH, Wanogho E, Perry PJ, Butler PC, Ijaz T, et al. The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1. Br J Cancer 2002; 86: 774-8.
38. Shin NH, Ryu SY, Choi EJ, Kang SH, Chang IM, Min KR, et al. Oxyresveratrol as the potent inhibitor on dopa oxidase activity of mushroom tyrosinase. Biochem Biophys Res Commun 1998; 243: 801-3.
39. Wietrzyk J, Grynkiewicz G, Opolski A. Phytoestrogens in cancer prevention and therapy: mechanisms of their biological activity. Anticancer Res 2005; 25: 2357-66.
40. Stopper H, Schmitt E, Kobras K. Genotoxicity of phytoestrogens. Mutat Res 2005; 574: 139-55.